Immuneering Corp (IMRX) SEC Filings — 2024

Filings

• Immuneering Corp SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Immuneering Corp SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Immuneering Corp Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
• Immuneering Corp Files 8-K/A Amendment — 8-K/A · Oct 2, 2024
• Pfizer to Acquire Immuneering Corp. — 8-K · Sep 12, 2024
• Immuneering Corp Files Q2 2024 10-Q — 10-Q · Aug 6, 2024
• Immuneering Corp. Files 8-K on Shareholder Vote Matters — 8-K · Jun 13, 2024
• Immuneering Corp Appoints New CMO, Elects Director — 8-K · May 23, 2024
• Immuneering Corp Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
• Immuneering Corp. Announces Annual Meeting of Stockholders on June 12, 2024 — DEF 14A · Apr 23, 2024
• Immuneering Corp SC 13G/A Filing — SC 13G/A · Apr 15, 2024
• Immuneering Corp SC 13G/A Filing — SC 13G/A · Apr 10, 2024
• Immuneering Corp SC 13G/A Filing — SC 13G/A · Apr 5, 2024
• Immuneering Corp SC 13G/A Filing — SC 13G/A · Mar 27, 2024
• Immuneering Corp Appoints New CMO and CSO — 8-K · Mar 14, 2024
• Immuneering Corp Files 2023 Annual Report on Form 10-K — 10-K · Mar 1, 2024
• Immuneering Corp SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Immuneering Corp SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Immuneering 8-K: Bylaw/Charter Amendment, Nasdaq Listing Confirmed — 8-K · Feb 2, 2024
• BlackRock Discloses 5.0% Stake in Immuneering Corp — SC 13G · Jan 26, 2024
• Immuneering Insider Zeskind Updates 3.68M Share Ownership — SC 13G/A · Jan 16, 2024